Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55:831–44.
2. Gerster JF. 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use. 1987. U.S. patent no. 4,689,338.
3. Özbağçıvan Ö, Ilknur T, Akarsu S, Lebe B, Fetil E. Oral leukoplakia: failure of topical imiquimod 5%. Turkderm Turkish Arch Dermatol Venereol. 2020;54:32–33.
4. Ramineni SK, Cunningham LL, Dziubla TD, Puleo DA. Development of imiquimod-loaded mucoadhesive films for oral dysplasia. J Pharm Sci. 2013;102:593–603.
5. de Mello Palma V, Frank LA, Balinha DM, Rados PV, Pohlmann AR, Guterres SS, et al. Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives. Br J Clin Pharmacol. 2024;90:427–39.